We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Prospective, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of Atrasentan, Including Thoracic Bioimpedance, in Type 2 Diabetic Subjects With Nephropathy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01399580
Recruitment Status : Completed
First Posted : July 22, 2011
Last Update Posted : October 25, 2013
Information provided by (Responsible Party):
AbbVie ( AbbVie (prior sponsor, Abbott) )

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : September 2012
  Study Completion Date : September 2012
  Certification or Request for Extension to Delay Results Submission: September 25, 2013